| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.8 |